311 related articles for article (PubMed ID: 34324967)
1. Recombinant production of Trx-Ib-AMP4 and Trx-E50-52 antimicrobial peptides and antimicrobial synergistic assessment on the treatment of methicillin-resistant Staphylococcus aureus under in vitro and in vivo situations.
Satei P; Ghaznavi-Rad E; Fahimirad S; Abtahi H
Protein Expr Purif; 2021 Dec; 188():105949. PubMed ID: 34324967
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal properties of the antimicrobial peptide Ib-AMP4 from Impatiens balsamina produced as a recombinant fusion-protein in Escherichia coli.
Fan X; Schäfer H; Reichling J; Wink M
Biotechnol J; 2013 Oct; 8(10):1213-20. PubMed ID: 23713064
[TBL] [Abstract][Full Text] [Related]
3. Ib-AMP4 antimicrobial peptide as a treatment for skin and systematic infection of methicillin-resistant
Sadelaji S; Ghaznavi-Rad E; Sadoogh Abbasian S; Fahimirad S; Abtahi H
Iran J Basic Med Sci; 2022 Feb; 25(2):232-238. PubMed ID: 35655604
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria.
Fan X; Reichling J; Wink M
Pharmazie; 2013 Jul; 68(7):628-30. PubMed ID: 23923648
[TBL] [Abstract][Full Text] [Related]
5. Hp1404, a new antimicrobial peptide from the scorpion Heterometrus petersii.
Li Z; Xu X; Meng L; Zhang Q; Cao L; Li W; Wu Y; Cao Z
PLoS One; 2014; 9(5):e97539. PubMed ID: 24826994
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial peptide Epinecidin-1 promotes complete skin regeneration of methicillin-resistant Staphylococcus aureus-infected burn wounds in a swine model.
Huang HN; Pan CY; Wu HY; Chen JY
Oncotarget; 2017 Mar; 8(13):21067-21080. PubMed ID: 28177877
[TBL] [Abstract][Full Text] [Related]
7. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS
Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of a new recombinant antimicrobial peptide, MP1102, against methicillin-resistant Staphylococcus aureus.
Zhang Y; Teng D; Wang X; Mao R; Cao X; Hu X; Zong L; Wang J
Appl Microbiol Biotechnol; 2015 Aug; 99(15):6255-66. PubMed ID: 25620367
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus.
Mohamed MF; Abdelkhalek A; Seleem MN
Sci Rep; 2016 Jul; 6():29707. PubMed ID: 27405275
[TBL] [Abstract][Full Text] [Related]
10. Effect of antimicrobial peptides HNP-1 and hBD-1 on Staphylococcus aureus strains in vitro and in vivo.
Bolatchiev A; Baturin V; Bazikov I; Maltsev A; Kunitsina E
Fundam Clin Pharmacol; 2020 Feb; 34(1):102-108. PubMed ID: 31313350
[TBL] [Abstract][Full Text] [Related]
11. Pse-T2, an Antimicrobial Peptide with High-Level, Broad-Spectrum Antimicrobial Potency and Skin Biocompatibility against Multidrug-Resistant Pseudomonas aeruginosa Infection.
Kang HK; Seo CH; Luchian T; Park Y
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30323036
[TBL] [Abstract][Full Text] [Related]
12. Database screening and in vivo efficacy of antimicrobial peptides against methicillin-resistant Staphylococcus aureus USA300.
Menousek J; Mishra B; Hanke ML; Heim CE; Kielian T; Wang G
Int J Antimicrob Agents; 2012 May; 39(5):402-6. PubMed ID: 22445495
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.
Mataraci E; Dosler S
Antimicrob Agents Chemother; 2012 Dec; 56(12):6366-71. PubMed ID: 23070152
[TBL] [Abstract][Full Text] [Related]
14. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Sakoulas G; Olson J; Yim J; Singh NB; Kumaraswamy M; Quach DT; Rybak MJ; Pogliano J; Nizet V
Antimicrob Agents Chemother; 2016 Nov; 60(11):6609-6618. PubMed ID: 27572414
[TBL] [Abstract][Full Text] [Related]
15.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[TBL] [Abstract][Full Text] [Related]
16. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
17. The biological synthesis of gold/perlite nanocomposite using Urtica dioica extract and its chitosan-capped derivative for healing wounds infected with methicillin-resistant Staphylococcus aureus.
Choodari Gharehpapagh A; Farahpour MR; Jafarirad S
Int J Biol Macromol; 2021 Jul; 183():447-456. PubMed ID: 33932414
[TBL] [Abstract][Full Text] [Related]
18. Identification of new dermaseptins with self-assembly tendency: membrane disruption, biofilm eradication, and infected wound healing efficacy.
Song X; Pan H; Wang H; Liao X; Sun D; Xu K; Chen T; Zhang X; Wu M; Wu D; Gao Y
Acta Biomater; 2020 Jun; 109():208-219. PubMed ID: 32276085
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Activity of Different Antimicrobial Peptides (AMPs) Against Clinical Methicillin-resistant Staphylococcus aureus (MRSA).
Ciandrini E; Morroni G; Arzeni D; Kamysz W; Neubauer D; Kamysz E; Cirioni O; Brescini L; Baffone W; Campana R
Curr Top Med Chem; 2018; 18(24):2116-2126. PubMed ID: 30345920
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model.
Mohammad H; Cushman M; Seleem MN
PLoS One; 2015; 10(11):e0142321. PubMed ID: 26536129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
